News
Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...
Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...
Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. By Kate Zernike To ...
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
2d
HealthDay on MSNUrticaria Reported in Trial of Investigational HIV mRNA VaccinesThe HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.
3h
News-Medical.Net on MSNNew AI tool predicts viral mutations to help future-proof COVID vaccinesA novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.
We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...
Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy ...
In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results